In vitro and in vivo analyses reveal significant anticancer activity of a Zn(II) complex, indicating potential as a chemotherapeutic agent.
The [Zn(LCX)(NCS)₂] complex demonstrated potent anticancer activity, followed by induction of apoptosis with minor host toxicity, positioning it as a viable option for advancement as an efficient chemotherapeutic agent. However, more research and clinical studies with animal and human models are needed to further develop the compound as a chemotherapeutic agent.
No takes yet. Share an insight, caveat, or question.
Soha et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: